The first patent for olmesartan medoxomil-hydrochlorothiazide currently expires in 2016. This is the earliest date that a generic version of the drug could become available. However, other circumstances could come up that extend the exclusivity period beyond 2016.
This could include such things as other patents for specific olmesartan medoxomil-hydrochlorothiazide uses or lawsuits. Once the medication goes off-patent, several companies may begin manufacturing a generic olmesartan medoxomil-hydrochlorothiazide. More.
I cant really gove you an answer,but what I can give you is a way to a solution, that is you have to find the anglde that you relate to or peaks your interest. A good paper is one that people get drawn into because it reaches them ln some way.As for me WW11 to me, I think of the holocaust and the effect it had on the survivors, their families and those who stood by and did nothing until it was too late.